Evidence map›Paper›PMID 33322208›Full record

ArticlePathogens (Basel, Switzerland)2020

Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients.

Beatrice Macchi, Caterina Frezza, Francesca Marino-Merlo, Antonella Minutolo, Valeria Stefanizzi, Emanuela Balestrieri, Carlotta Cerva, Loredana Sarmati, Massimo Andreoni, Sandro Grelli and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Beatrice MacchiDepartment of Chemical Science and Technology, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0003-0878-1799
Caterina FrezzaDepartment of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Francesca Marino-MerloDepartment of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, 98166 Messina, Italy.ORCID 0000-0001-7898-583X
Antonella MinutoloDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0003-4784-4297
Valeria StefanizziDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Emanuela BalestrieriDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Carlotta CervaDepartment of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Loredana SarmatiDepartment of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0003-1452-0333
Massimo AndreoniDepartment of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Sandro GrelliDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Antonio MastinoThe Institute of Translational Pharmacology, CNR, 00133 Rome, Italy.ORCID 0000-0002-0338-6450
University of Rome Tor Vergata · ITIstituto di Farmacologia Traslazionale · ITUniversity of Messina · IT

Funding

Gilead Sciences s.r.l. Fellowship Program 2018Italian Ministry of University and Research, PRIN n. 2017M8R7N9_002,
6 · The paper itself

Abstract

Testing HIV-1 RNA in plasma by PCR is universally accepted as the ultimate standard to confirm diagnosis of HIV-1 infection and to monitor viral load in patients under treatment. However, in some cases, this assay could either underestimate or overestimate the replication capacity of a circulating or latent virus. In the present study, we performed the assessment of evaluating the HIV-1 reverse transcriptase (RT) activity by means of a new assay for the functional screening of the status of HIV-1 patients. To this purpose, we utilized, for the first time on blood samples, an adapted version of a real-time RT quantitative PCR assay, utilized to evaluate the HIV-1-RT inhibitory activity of compounds. The study analyzed blood samples from 28 HIV-1-infected patients, exhibiting a wide range of viremia and immunological values. Results demonstrated that plasma HIV-1 RT levels, expressed as cycle threshold values obtained with the assay under appraisal, were inversely and highly significantly correlated with the plasma HIV-1-RNA levels of the patients. Thus, an HIV-1 RT quantitative PCR assay was created which we describe in this study, and it may be considered as a promising basis for an additional tool capable of furnishing information on the functional virological status of HIV-1-infected patients.

Indexed as

HIV diagnosticshuman immunodeficiency virusquantitative PCR assayreverse transcriptaseviral load

Identifiers

PMID33322208
PMCPMC7763350
OpenAlexW3112856567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.